Sign in
8-K

Current Report

CRISPR Therapeutics AG Filed Acc 0001193125-18-265036

Material agreement

  • Item 1.01 Entry into a material definitive agreement

From the SEC's structured data for this filing

Loading d618174d8k.htm…